$21.83
-0.230 (-1.04%)
At Close: Jul 31, 2026
$500 per Month in Passive Income – Invest This Much in These 3 Monthly Dividend Stocks
12:09pm, Monday, 30'th Mar 2026
$500 per month may seem small, but it's not a trivial amount and can snowball your portfolio quickly.
Wealth Enhancement Advisory Services LLC Cuts Holdings in Healthpeak Properties, Inc. $DOC
05:10am, Monday, 30'th Mar 2026
Wealth Enhancement Advisory Services LLC decreased its stake in Healthpeak Properties, Inc. (NYSE: DOC) by 37.4% during the fourth quarter, according to its most recent filing with the Securities and
Conflict Without Closure
09:00am, Sunday, 29'th Mar 2026
U.S. equity markets fell for a fifth-straight week— pulling several major benchmarks into correction territory— as the Iran conflict remained locked in a volatile stalemate, keeping energy markets
Healthpeak Properties, Inc. $DOC Stock Position Lessened by DAVENPORT & Co LLC
04:21am, Thursday, 26'th Mar 2026
DAVENPORT and Co LLC trimmed its holdings in shares of Healthpeak Properties, Inc. (NYSE: DOC) by 9.5% during the fourth quarter, according to its most recent Form 13F filing with the SEC. The firm ow
REITs: A Regime Change Is Needed
02:03pm, Tuesday, 24'th Mar 2026
REITs were rolling out of the gates in early-2026, coming back into favor amid a HALO trade (Heavy Assets, Low Obsolescence) after a half-decade of rate headwinds and unfavorable narrative. The oil pr
Press release – No. 6 / 2026 Zealand Pharma Establishes U.S. Research Hub in Cambridge, Massachusetts to Expand Drug Discovery Capabilities and Accelerate Medicine Creation New research hub in Cambr
Healthpeak Properties Closes New $400 Million Delayed-Draw Term Loan Facility
04:16pm, Monday, 23'rd Mar 2026
DENVER--(BUSINESS WIRE)--Healthpeak Properties, Inc. (NYSE: DOC) (“Healthpeak”), a leading owner, operator, and developer of real estate for healthcare discovery and delivery, announced today that
Healthpeak Properties and Janus Living Announce Closing of Janus Living Initial Public Offering
04:15pm, Monday, 23'rd Mar 2026
DENVER--(BUSINESS WIRE)--Healthpeak Properties, Inc. (NYSE: DOC) (“Healthpeak”) and Janus Living, Inc. (NYSE: JAN) (“Janus Living”) announced today that Janus Living has completed its initial
Why Healthpeak Properties Is Of Interest To Me At This Price
02:25pm, Monday, 23'rd Mar 2026
Healthpeak Properties is rated a "Buy," driven by undervaluation and a 7.16% yield. DOC's strategic shift from SHOP to labs and outpatient medical buildings increases capital intensity and AFFO volati
Should You Buy the 3 Highest-Paying Dividend Stocks in the S&P 500?
08:08am, Monday, 23'rd Mar 2026
Campbell's boasts many market-leading brands, and it's working to improve its performance. Healthpeak Properties is a real estate investment trust (REIT) with many medical buildings and laboratories.
5 ‘Healthy' Dividends Paying Up To 14.1%
09:45am, Sunday, 22'nd Mar 2026
Healthcare dividend stocks are selling off with the turbulence in the Middle East.
The Strait Squeeze
09:00am, Sunday, 22'nd Mar 2026
U.S. equity markets fell for a fourth straight week, while interest rates jumped to eight-month highs, as continued turmoil in the Middle East rattled financial markets and revived inflation concerns.
What Active REIT Managers Bought And Sold In Q4 2025
07:15am, Saturday, 21'st Mar 2026
Top REIT investors are quietly repositioning their portfolios, revealing where the “smart money” sees opportunity. Several clear sector themes are emerging from recent 13F filings. But the biggest
Healthpeak Properties and Janus Living Announce Pricing of Upsized $840 Million Janus Living Initial Public Offering
04:35pm, Thursday, 19'th Mar 2026
DENVER--(BUSINESS WIRE)--Healthpeak Properties, Inc. (NYSE: DOC) (“Healthpeak”) and Janus Living, Inc. (“Janus Living”) announced the pricing of Janus Living's upsized initial public offering
2 Reliable And Undervalued Dividends For Passive Income
08:30am, Thursday, 19'th Mar 2026
Verizon is executing a turnaround, leveraging network infrastructure, fiber expansion, and cost efficiencies to drive subscriber growth and sustainable cash flow. VZ remains undervalued at a forward P
Sign In
Buy DOC